Boston Advisors’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-8,639
Closed -$428K 818
2015
Q2
$428K Sell
8,639
-3,527
-29% -$175K 0.02% 520
2015
Q1
$953K Buy
12,166
+9,534
+362% +$747K 0.04% 298
2014
Q4
$159K Buy
+2,632
New +$159K 0.01% 576